Description

Drug Classification:

Fluvoxamine maleate belongs to the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by increasing the levels of serotonin, a neurotransmitter in the brain, which helps regulate mood, emotions, and behavior. By enhancing serotonin activity, fluvoxamine alleviates symptoms associated with depression, anxiety disorders, and obsessive-compulsive disorder (OCD).

Formulations:

• Fluvoxamine Maleate Tablets:
  • Strengths: Available in 50mg and 100mg tablets.
  • Product Form: Oral tablets for convenient administration.
  • Packing Specs: Each pack contains 10 tablets.

Indications:

Fluvoxamine Maleate Tablets are indicated for the treatment of:

• Major Depressive Disorder (MDD): Fluvoxamine helps alleviate symptoms of depression, including persistent sadness, loss of interest or pleasure, and changes in appetite or sleep patterns.
• Obsessive-Compulsive Disorder (OCD): Fluvoxamine is effective in reducing the frequency and intensity of obsessive thoughts and compulsive behaviors.
• Social Anxiety Disorder (SAD): Fluvoxamine can help manage symptoms of social anxiety, such as excessive fear or avoidance of social situations.
• Panic Disorder: Fluvoxamine may be prescribed to reduce the frequency and severity of panic attacks, including associated symptoms of palpitations, sweating, and trembling.

Usage:

• Fluvoxamine Maleate Tablets should be taken orally, with or without food, as directed by a healthcare professional.
• It is important to adhere to the prescribed dosage and dosing schedule to achieve optimal therapeutic outcomes.
• The duration of treatment may vary depending on the individual’s response to therapy and the severity of the underlying condition.

Dosage:

• The recommended starting dose of fluvoxamine for adults is typically 50mg once daily, administered in the evening.
• Dosage adjustments may be made based on the individual’s response and tolerability, with a maximum daily dose of 300mg.
• Elderly patients and individuals with hepatic or renal impairment may require lower initial doses and careful dose titration under medical supervision.

Pharmacokinetics:

• Following oral administration, fluvoxamine is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations achieved within 4 to 8 hours.
• Fluvoxamine undergoes extensive metabolism in the liver via the cytochrome P450 enzyme system, primarily CYP2D6 and CYP1A2.
• The elimination half-life of fluvoxamine ranges from 15 to 24 hours, allowing for once-daily dosing in most patients.

Pharmacodynamics:

• Fluvoxamine selectively inhibits the reuptake of serotonin at neuronal synapses, leading to increased serotonin levels in the brain.
• By enhancing serotonergic neurotransmission, fluvoxamine helps regulate mood, reduce anxiety, and alleviate symptoms of OCD.
• The therapeutic effects of fluvoxamine may take several weeks to become fully apparent, necessitating patience and adherence to treatment.

Side Effects:

• Common side effects associated with fluvoxamine may include nausea, vomiting, diarrhea, dizziness, drowsiness, and insomnia.
• Less frequently reported adverse reactions may include headache, dry mouth, blurred vision, and sexual dysfunction.
• In rare instances, fluvoxamine may be associated with more serious adverse events such as serotonin syndrome, suicidal ideation, or allergic reactions.

Trust in the efficacy and safety of Fluvoxamine Maleate Tablets from AIT Pharmaceuticals Division. Whether you are seeking relief from depression, anxiety, or OCD, our product offers a reliable solution to help you regain control and lead a more fulfilling life. For more information, please visit our website or consult your healthcare provider.